5,625-share Rule 144 sale at Blend Labs (NASDAQ: BLND)

Rhea-AI Filing Summary

Blend Labs, Inc. submitted a Rule 144 notice reporting the sale/offer of 5,625 common shares tied to a restricted stock lapse dated 02/20/2026. The filing also discloses a prior sale of 2,500 common shares on 01/07/2026, producing a cumulative figure shown as 7,725 in the excerpt.

Insights

Securities Compliance Analyst

Rule 144 notice records a restricted stock lapse and subsequent sale activity.

The excerpt lists 5,625 common shares associated with a restricted stock lapse dated 02/20/2026. It separately shows a sale of 2,500 shares on 01/07/2026 and a cumulative line of 7,725.

These entries appear to document compliance with resale rules; timing and cash‑flow treatment are not stated in the excerpt. Subsequent filings or broker confirmations would show actual sale execution and proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	5625	8955.00	256119535	02/24/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2026	Restricted Stock Lapse	BLEND LABS, INC.			5625	02/20/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
OXANA TKACH 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	01/07/2026	2500	7725.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Blend Labs (BLND) Form 144 report?

It reports a Rule 144 notice for 5,625 common shares dated 02/20/2026. The excerpt also records a prior sale of 2,500 shares on 01/07/2026, with a cumulative figure shown as 7,725 in the provided lines.

Who is identified as the seller in the provided Blend Labs excerpt?

The excerpt names Oxana Tkach with an address in Novato, CA. The filing lines show broker information for Charles Schwab & Co. and list the securities and dates related to the restricted stock lapse and past sale.

Does the Form 144 excerpt state proceeds or sale price for BLND shares?

No sale proceeds or prices are shown in the provided excerpt. The lines list share counts and dates only; they do not disclose cash amounts or execution details for the reported transactions.

What does 'restricted stock lapse' mean in this context for BLND?

It indicates restrictions on the shares expired on 02/20/2026, permitting a resale under Rule 144. The excerpt ties the 5,625 shares to that lapse and classifies the source as equity compensation.

Are the cumulative share figures in the excerpt confirming total holdings?

The excerpt shows a cumulative line of 7,725, but it does not explicitly label total holdings. The numbers reflect reported dispositions and related counts in the filing excerpt rather than a clear statement of current beneficial ownership.